Enter your login e-mail to the account
Search
- Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Relevance of the PI3K signaling pathway in advanced breast cancer and the possibilities of targeted treatment
MUDr. Bela Mriňáková, PhD., MPH
(5/2020, Review articles ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes )